SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : SPIN-OFFS "secret hiding places of stock market profits" -- Ignore unavailable to you. Want to Upgrade?


To: Paul Senior who wrote (296)2/20/1999 1:29:00 AM
From: Stewart Whitman  Respond to of 1185
 
One of the best things about following spin-offs is you begin to see sectors where the industries are truly in a restructuring phase. The chemical industry, over the past year has been in such a phase. Several chemical companies have been persued an aggressive strategy of separating their "fast growing" parts from the "no/low growth" commodity parts:

Great Lakes - ? (growth)
Octel - lead gasoline additive,other (commodity)

Olin - ammunitions,brass,chlor alkali (commodity products)
Arch Chemical - high-purity,water,microelectronics (growth)

General Chemical - soda ash, calcium chloride (commodity)
Gentek - auto parts,performance chemicals (growth)

Akzo Nobel - healthcare,coatings,chemicals ?
Acordis - polymers ?

I was surprised to see so many reasonably-sized and similar spin-offs from the same industry. The commodity parts seem to be doing terribly, but the growth parts look very attractive when valued at the multiples of the parent. I traded the Olin I had in for Arch when the when-issued shares were at 15. Olin had been investing heavily in those segments - new plants, etc. - there should be some P/E expansion. I'll be looking for a similar opportunity when the Gentek spin-off comes around (although I'm not quite comfortable with a single majority shareholder). And, I'm still holding my Octel shares...ZZZZ. Haven't looked at Acordis yet.

Stew